Grant Number:	1R01CA083855-01 Interpret this number
Primary Investigator:	Rebbeck, Timothy
Organization:	University Of Pennsylvania
Project Title:	Prophylactic Surgery in Carriers of BRCA1 and Brca2
Fiscal Year:	2000

DESCRIPTION: (Adapted from the Investigator's Abstract) The availability of genetic testing for inherited mutations in the BRCA1 and BRCA2 genes provides potentially valuable information to women at high risk of breast or ovarian cancer. Unfortunately, carriers of these mutations have relatively few clinical management options to reduce their cancer risk. The investigators propose a study in response to the NCI's program announcement "Clinical Epidemiology Studies in Hereditary Breast/Ovarian Cancer". They propose to evaluate the role of prophylactic surgery in reducing breast and ovarian cancer risk and mortality in BRCA1 and BRCA2 mutation carriers. Specifically, they propose: 1) to estimate the reduction in cancer risk following prophylactic surgery; 2) to estimate the reduction in cancer mortality following prophylactic surgery; 3) to evaluate differences in type of prophylactic mastectomy in breast cancer risk reduction; and 4) evaluate the psychosocial implications of prophylactic mastectomy or prophylactic oophorectomy, including measurement of mental health, satisfaction and quality of life. Two groups of women will be studied. Surgical subjects are those women who have undergone a bilateral prophylactic mastectomy (BPM) or prophylactic oophorectomy (BPO). Women will be followed-up over the course of this project to identify new occurrences of cancer surgery, or other relevant events. This follow-up will also yield longitudinal information about psychosocial adjustment to surgery including distress, depression, quality of life, satisfaction, and vulnerability to subsequent events. The risk of cancer in women who have undergone prophylactic surgery will be compared with cancer risk in controls that have no history of BPM or BPO. All study participants will carry documented disease-causing germline BRCA1/2 mutations. Analyses will be undertaken to specifically evaluate risk and mortality reduction following surgery. As recognized by this program announcement, women who have inherited germline BRCA1/2 mutations and are at extremely high risk of breast and ovarian cancer "must make decisions about managing their cancer risk Ywith only limited scientific information about Ythe efficacy of prophylactic surgery". The announcement further recognizes that "While prospective studies will eventually provide definitive answers to these question, there is an immediate need to address these issues through retrospective studies based on existing resources such as tissue banks and high-risk clinic registries and research projects". This proposal will address that immediate and important clinical need.




Precision prophylaxis: Identifying the optimal timing for risk-reducing salpingo-oophorectomy based on type of BRCA1 and BRCA2 cluster region mutations.
Authors: Solsky I. , Chen J. , Rebbeck T.R. .
Source: Gynecologic Oncology, 2020 02; 156(2), p. 363-376.
EPub date: 2020-01-07 00:00:00.0.
PMID: 31918993
Related Citations

BRCA1 and BRCA2 Pathogenic Sequence Variants in Women of African Origin or Ancestry.
Authors: Friebel T.M. , Andrulis I.L. , Balmaña J. , Blanco A.M. , Couch F.J. , Daly M.B. , Domchek S.M. , Easton D.F. , Foulkes W.D. , Ganz P.A. , et al. .
Source: Human Mutation, 2019-05-21 00:00:00.0; , .
EPub date: 2019-05-21 00:00:00.0.
PMID: 31112363
Related Citations

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.
Authors: Figlioli G. , Bogliolo M. , Catucci I. , Caleca L. , Lasheras S.V. , Pujol R. , Kiiski J.I. , Muranen T.A. , Barnes D.R. , Dennis J. , et al. .
Source: Npj Breast Cancer, 2019; 5, p. 38.
EPub date: 2019-11-01 00:00:00.0.
PMID: 31700994
Related Citations

Breast and ovarian cancer penetrance of BRCA1/2 mutations among Hong Kong women.
Authors: Zhang L. , Shin V.Y. , Chai X. , Zhang A. , Chan T.L. , Ma E.S. , Rebbeck T.R. , Chen J. , Kwong A. .
Source: Oncotarget, 2018-05-18 00:00:00.0; 9(38), p. 25025-25033.
EPub date: 2018-02-02 00:00:00.0.
PMID: 29861850
Related Citations

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Authors: Rebbeck T.R. , Friebel T.M. , Friedman E. , Hamann U. , Huo D. , Kwong A. , Olah E. , Olopade O.I. , Solano A.R. , Teo S.H. , et al. .
Source: Human Mutation, 2018 May; 39(5), p. 593-620.
EPub date: 2018-03-12 00:00:00.0.
PMID: 29446198
Related Citations

Evaluation Of Copy-number Variants As Modifiers Of Breast And Ovarian Cancer Risk For Brca1 Pathogenic Variant Carriers
Authors: Walker L.C. , Marquart L. , Pearson J.F. , Wiggins G.A. , O'Mara T.A. , Parsons M.T. , BCFR , Barrowdale D. , McGuffog L. , Dennis J. , et al. .
Source: European Journal Of Human Genetics : Ejhg, 2017 Apr; 25(4), p. 432-438.
PMID: 28145423
Related Citations

Inheritance Of Deleterious Mutations At Both Brca1 And Brca2 In An International Sample Of 32,295 Women
Authors: Rebbeck T.R. , Friebel T.M. , Mitra N. , Wan F. , Chen S. , Andrulis I.L. , Apostolou P. , Arnold N. , Arun B.K. , Barrowdale D. , et al. .
Source: Breast Cancer Research : Bcr, 2016-11-11 00:00:00.0; 18(1), p. 112.
PMID: 27836010
Related Citations

Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.
Authors: Shu C.A. , Pike M.C. , Jotwani A.R. , Friebel T.M. , Soslow R.A. , Levine D.A. , Nathanson K.L. , Konner J.A. , Arnold A.G. , Bogomolniy F. , et al. .
Source: Jama Oncology, 2016-11-01 00:00:00.0; 2(11), p. 1434-1440.
PMID: 27367496
Related Citations

Association Of Breast Cancer Risk In Brca1 And Brca2 Mutation Carriers With Genetic Variants Showing Differential Allelic Expression: Identification Of A Modifier Of Breast Cancer Risk At Locus 11q22.3
Authors: Hamdi Y. , Soucy P. , Kuchenbaeker K.B. , Pastinen T. , Droit A. , Lemaçon A. , Adlard J. , Aittomäki K. , Andrulis I.L. , Arason A. , et al. .
Source: Breast Cancer Research And Treatment, 2016-10-28 00:00:00.0; , .
PMID: 27796716
Related Citations

Functional Mechanisms Underlying Pleiotropic Risk Alleles At The 19p13.1 Breast-ovarian Cancer Susceptibility Locus
Authors: Lawrenson K. , Kar S. , McCue K. , Kuchenbaeker K. , Michailidou K. , Tyrer J. , Beesley J. , Ramus S.J. , Li Q. , Delgado M.K. , et al. .
Source: Nature Communications, 2016-09-07 00:00:00.0; 7, p. 12675.
PMID: 27601076
Related Citations

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.
Authors: Zeng C. , Guo X. , Long J. , Kuchenbaecker K.B. , Droit A. , Michailidou K. , Ghoussaini M. , Kar S. , Freeman A. , Hopper J.L. , et al. .
Source: Breast Cancer Research : Bcr, 2016-06-21 00:00:00.0; 18(1), p. 64.
EPub date: 2016-06-21 00:00:00.0.
PMID: 27459855
Related Citations

No Clinical Utility Of Kras Variant Rs61764370 For Ovarian Or Breast Cancer
Authors: Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, and Consortium of Modifiers of BRCA1 and BRCA2 , Hollestelle A. , van der Baan F.H. , Berchuck A. , Johnatty S.E. , Aben K.K. , Agnarsson B.A. , Aittomäki K. , Alducci E. , Andrulis I.L. , et al. .
Source: Gynecologic Oncology, 2016 May; 141(2), p. 386-401.
PMID: 25940428
Related Citations

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.
Authors: Silvestri V. , Barrowdale D. , Mulligan A.M. , Neuhausen S.L. , Fox S. , Karlan B.Y. , Mitchell G. , James P. , Thull D.L. , Zorn K.K. , et al. .
Source: Breast Cancer Research : Bcr, 2016-02-09 00:00:00.0; 18(1), p. 15.
EPub date: 2016-02-09 00:00:00.0.
PMID: 26857456
Related Citations

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.
Authors: Blein S. , Bardel C. , Danjean V. , McGuffog L. , Healey S. , Barrowdale D. , Lee A. , Dennis J. , Kuchenbaecker K.B. , Soucy P. , et al. .
Source: Breast Cancer Research : Bcr, 2015-04-25 00:00:00.0; 17, p. 61.
EPub date: 2015-04-25 00:00:00.0.
PMID: 25925750
Related Citations

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
Authors: Rebbeck T.R. , Mitra N. , Wan F. , Sinilnikova O.M. , Healey S. , McGuffog L. , Mazoyer S. , Chenevix-Trench G. , Easton D.F. , Antoniou A.C. , et al. .
Source: Jama, 2015-04-07 00:00:00.0; 313(13), p. 1347-61.
PMID: 25849179
Related Citations

Candidate Genetic Modifiers For Breast And Ovarian Cancer Risk In Brca1 And Brca2 Mutation Carriers
Authors: Peterlongo P. , Chang-Claude J. , Moysich K.B. , Rudolph A. , Schmutzler R.K. , Simard J. , Soucy P. , Eeles R.A. , Easton D.F. , Hamann U. , et al. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2015 Jan; 24(1), p. 308-16.
PMID: 25336561
Related Citations

Assessing Associations Between The Aurka-hmmr-tpx2-tubg1 Functional Module And Breast Cancer Risk In Brca1/2 Mutation Carriers
Authors: Blanco I. , Kuchenbaecker K. , Cuadras D. , Wang X. , Barrowdale D. , de Garibay G.R. , Librado P. , Sánchez-Gracia A. , Rozas J. , Bonifaci N. , et al. .
Source: Plos One, 2015; 10(4), p. e0120020.
PMID: 25830658
Related Citations

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.
Authors: Spurdle A.B. , Couch F.J. , Parsons M.T. , McGuffog L. , Barrowdale D. , Bolla M.K. , Wang Q. , Healey S. , Schmutzler R. , Wappenschmidt B. , et al. .
Source: Breast Cancer Research : Bcr, 2014-12-23 00:00:00.0; 16(6), p. 3419.
EPub date: 2014-12-23 00:00:00.0.
PMID: 25857409
Related Citations

Use Of Risk-reducing Surgeries In A Prospective Cohort Of 1,499 Brca1 And Brca2 Mutation Carriers
Authors: Chai X. , Friebel T.M. , Singer C.F. , Evans D.G. , Lynch H.T. , Isaacs C. , Garber J.E. , Neuhausen S.L. , Matloff E. , Eeles R. , et al. .
Source: Breast Cancer Research And Treatment, 2014 Nov; 148(2), p. 397-406.
PMID: 25311111
Related Citations

Associations Of Common Breast Cancer Susceptibility Alleles With Risk Of Breast Cancer Subtypes In Brca1 And Brca2 Mutation Carriers
Authors: Kuchenbaecker K.B. , Neuhausen S.L. , Robson M. , Barrowdale D. , McGuffog L. , Mulligan A.M. , Andrulis I.L. , Spurdle A.B. , Schmidt M.K. , Schmutzler R.K. , et al. .
Source: Breast Cancer Research : Bcr, 2014; 16(6), p. 3416.
PMID: 25919761
Related Citations

Identification Of A Brca2-specific Modifier Locus At 6p24 Related To Breast Cancer Risk
Authors: Gaudet M.M. , Kuchenbaecker K.B. , Vijai J. , Klein R.J. , Kirchhoff T. , McGuffog L. , Barrowdale D. , Dunning A.M. , Lee A. , Dennis J. , et al. .
Source: Plos Genetics, 2013; 9(3), p. e1003173.
PMID: 23544012
Related Citations

Genome-wide Association Study In Brca1 Mutation Carriers Identifies Novel Loci Associated With Breast And Ovarian Cancer Risk
Authors: Couch F.J. , Wang X. , McGuffog L. , Lee A. , Olswold C. , Kuchenbaecker K.B. , Soucy P. , Fredericksen Z. , Barrowdale D. , Dennis J. , et al. .
Source: Plos Genetics, 2013; 9(3), p. e1003212.
PMID: 23544013
Related Citations

Evaluation Of Chromosome 6p22 As A Breast Cancer Risk Modifier Locus In A Follow-up Study Of Brca2 Mutation Carriers
Authors: Stevens K.N. , Wang X. , Fredericksen Z. , Pankratz V.S. , Greene M.H. , Andrulis I.L. , Thomassen M. , Caligo M. , Swedish Breast Cancer Study, Sweden (SWE-BRCA) , Nathanson K.L. , et al. .
Source: Breast Cancer Research And Treatment, 2012 Nov; 136(1), p. 295-302.
PMID: 23011509
Related Citations

A Nonsynonymous Polymorphism In Irs1 Modifies Risk Of Developing Breast And Ovarian Cancers In Brca1 And Ovarian Cancer In Brca2 Mutation Carriers
Authors: Ding Y.C. , McGuffog L. , Healey S. , Friedman E. , Laitman Y. , Paluch-Shimon S. , Kaufman B. , SWE-BRCA , Liljegren A. , Lindblom A. , et al. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2012 Aug; 21(8), p. 1362-70.
PMID: 22729394
Related Citations

Association Of Phb 1630 C>t And Mthfr 677 C>t Polymorphisms With Breast And Ovarian Cancer Risk In Brca1/2 Mutation Carriers: Results From A Multicenter Study
Authors: Jakubowska A. , Rozkrut D. , Antoniou A. , Hamann U. , Scott R.J. , McGuffog L. , Healy S. , Sinilnikova O.M. , Rennert G. , Lejbkowicz F. , et al. .
Source: British Journal Of Cancer, 2012-06-05 00:00:00.0; 106(12), p. 2016-24.
PMID: 22669161
Related Citations

Breast And Ovarian Cancer Risk And Risk Reduction In Jewish Brca1/2 Mutation Carriers
Authors: Finkelman B.S. , Rubinstein W.S. , Friedman S. , Friebel T.M. , Dubitsky S. , Schonberger N.S. , Shoretz R. , Singer C.F. , Blum J.L. , Tung N. , et al. .
Source: Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology, 2012-04-20 00:00:00.0; 30(12), p. 1321-8.
PMID: 22430266
Related Citations

Ovarian Cancer Susceptibility Alleles And Risk Of Ovarian Cancer In Brca1 And Brca2 Mutation Carriers
Authors: Ramus S.J. , Antoniou A.C. , Kuchenbaecker K.B. , Soucy P. , Beesley J. , Chen X. , McGuffog L. , Sinilnikova O.M. , Healey S. , Barrowdale D. , et al. .
Source: Human Mutation, 2012 Apr; 33(4), p. 690-702.
PMID: 22253144
Related Citations

Common Variants At The 19p13.1 And Znf365 Loci Are Associated With Er Subtypes Of Breast Cancer And Ovarian Cancer Risk In Brca1 And Brca2 Mutation Carriers
Authors: Couch F.J. , Gaudet M.M. , Antoniou A.C. , Ramus S.J. , Kuchenbaecker K.B. , Soucy P. , Beesley J. , Chen X. , Wang X. , Kirchhoff T. , et al. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2012 Apr; 21(4), p. 645-57.
PMID: 22351618
Related Citations

Non-cancer Endpoints In Brca1/2 Carriers After Risk-reducing Salpingo-oophorectomy
Authors: Cohen,J.V. , Chiel,L. , Boghossian,L. , Jones,M. , Stopfer,J.E. , Powers,J. , Rebbeck,T.R. , Nathanson,K.L. , Domchek,S.M. .
Source: Familial Cancer, 2012 Mar; 11(1), p. 69-75.
PMID: 21898151
Related Citations

Common Variants Of The Brca1 Wild-type Allele Modify The Risk Of Breast Cancer In Brca1 Mutation Carriers
Authors: Cox D.G. , Simard J. , Sinnett D. , Hamdi Y. , Soucy P. , Ouimet M. , Barjhoux L. , Verny-Pierre C. , McGuffog L. , Healey S. , et al. .
Source: Human Molecular Genetics, 2011-12-01 00:00:00.0; 20(23), p. 4732-47.
PMID: 21890493
Related Citations

Modification Of Brca1-associated Breast And Ovarian Cancer Risk By Brca1-interacting Genes
Authors: Rebbeck T.R. , Mitra N. , Domchek S.M. , Wan F. , Friebel T.M. , Tran T.V. , Singer C.F. , Tea M.K. , Blum J.L. , Tung N. , et al. .
Source: Cancer Research, 2011-09-01 00:00:00.0; 71(17), p. 5792-805.
PMID: 21799032
Related Citations

Common Alleles At 6q25.1 And 1p11.2 Are Associated With Breast Cancer Risk For Brca1 And Brca2 Mutation Carriers
Authors: Antoniou A.C. , Kartsonaki C. , Sinilnikova O.M. , Soucy P. , McGuffog L. , Healey S. , Lee A. , Peterlongo P. , Manoukian S. , Peissel B. , et al. .
Source: Human Molecular Genetics, 2011-08-15 00:00:00.0; 20(16), p. 3304-21.
PMID: 21593217
Related Citations

Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers.
Authors: Neuhausen S.L. , Brummel S. , Ding Y.C. , Steele L. , Nathanson K.L. , Domchek S. , Rebbeck T.R. , Singer C.F. , Pfeiler G. , Lynch H.T. , et al. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2011 Aug; 20(8), p. 1690-702.
PMID: 21708937
Related Citations

Common Genetic Variation At Bard1 Is Not Associated With Breast Cancer Risk In Brca1 Or Brca2 Mutation Carriers
Authors: Spurdle A.B. , Marquart L. , McGuffog L. , Healey S. , Sinilnikova O. , Wan F. , Chen X. , Beesley J. , Singer C.F. , Dressler A.C. , et al. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2011 May; 20(5), p. 1032-8.
PMID: 21393566
Related Citations

Common Breast Cancer Susceptibility Alleles And The Risk Of Breast Cancer For Brca1 And Brca2 Mutation Carriers: Implications For Risk Prediction
Authors: Antoniou A.C. , Beesley J. , McGuffog L. , Sinilnikova O.M. , Healey S. , Neuhausen S.L. , Ding Y.C. , Rebbeck T.R. , Weitzel J.N. , Lynch H.T. , et al. .
Source: Cancer Research, 2010-12-01 00:00:00.0; 70(23), p. 9742-54.
PMID: 21118973
Related Citations

Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers.
Authors: Domchek S.M. , Friebel T.M. , Garber J.E. , Isaacs C. , Matloff E. , Eeles R. , Evans D.G. , Rubinstein W. , Singer C.F. , Rubin S. , et al. .
Source: Breast Cancer Research And Treatment, 2010 Nov; 124(1), p. 195-203.
PMID: 20180014
Related Citations

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Authors: Domchek S.M. , Friebel T.M. , Singer C.F. , Evans D.G. , Lynch H.T. , Isaacs C. , Garber J.E. , Neuhausen S.L. , Matloff E. , Eeles R. , et al. .
Source: Jama, 2010-09-01 00:00:00.0; 304(9), p. 967-75.
PMID: 20810374
Related Citations

Pooled Analysis Indicates That The Gstt1 Deletion, Gstm1 Deletion, And Gstp1 Ile105val Polymorphisms Do Not Modify Breast Cancer Risk In Brca1 And Brca2 Mutation Carriers
Authors: Spurdle A.B. , Fahey P. , Chen X. , McGuffog L. , kConFab , Easton D. , Peock S. , Cook M. , EMBRACE , Simard J. , et al. .
Source: Breast Cancer Research And Treatment, 2010 Jul; 122(1), p. 281-5.
PMID: 19921428
Related Citations

Modification Of Ovarian Cancer Risk By Brca1/2-interacting Genes In A Multicenter Cohort Of Brca1/2 Mutation Carriers
Authors: Rebbeck T.R. , Mitra N. , Domchek S.M. , Wan F. , Chuai S. , Friebel T.M. , Panossian S. , Spurdle A. , Chenevix-Trench G. , kConFab , et al. .
Source: Cancer Research, 2009-07-15 00:00:00.0; 69(14), p. 5801-10.
PMID: 19584272
Related Citations

Meta-analysis Of Risk Reduction Estimates Associated With Risk-reducing Salpingo-oophorectomy In Brca1 Or Brca2 Mutation Carriers
Authors: Rebbeck T.R. , Kauff N.D. , Domchek S.M. .
Source: Journal Of The National Cancer Institute, 2009-01-21 00:00:00.0; 101(2), p. 80-7.
PMID: 19141781
Related Citations

Genetic Variation In Insulin-like Growth Factor Signaling Genes And Breast Cancer Risk Among Brca1 And Brca2 Carriers
Authors: Neuhausen S.L. , Brummel S. , Ding Y.C. , Singer C.F. , Pfeiler G. , Lynch H.T. , Nathanson K.L. , Rebbeck T.R. , Garber J.E. , Couch F. , et al. .
Source: Breast Cancer Research : Bcr, 2009; 11(5), p. R76.
PMID: 19843326
Related Citations

Common Breast Cancer-predisposition Alleles Are Associated With Breast Cancer Risk In Brca1 And Brca2 Mutation Carriers
Authors: Antoniou A.C. , Spurdle A.B. , Sinilnikova O.M. , Healey S. , Pooley K.A. , Schmutzler R.K. , Versmold B. , Engel C. , Meindl A. , Arnold N. , et al. .
Source: American Journal Of Human Genetics, 2008 Apr; 82(4), p. 937-48.
PMID: 18355772
Related Citations

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Authors: Kauff N.D. , Domchek S.M. , Friebel T.M. , Robson M.E. , Lee J. , Garber J.E. , Isaacs C. , Evans D.G. , Lynch H. , Eeles R.A. , et al. .
Source: Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology, 2008-03-10 00:00:00.0; 26(8), p. 1331-7.
EPub date: 2008-03-10 00:00:00.0.
PMID: 18268356
Related Citations

Factors Determining Dissemination Of Results And Uptake Of Genetic Testing In Families With Known Brca1/2 Mutations
Authors: Finlay E. , Stopfer J.E. , Burlingame E. , Evans K.G. , Nathanson K.L. , Weber B.L. , Armstrong K. , Rebbeck T.R. , Domchek S.M. .
Source: Genetic Testing, 2008 Mar; 12(1), p. 81-91.
PMID: 18373407
Related Citations

Rad51 135g-->c Modifies Breast Cancer Risk Among Brca2 Mutation Carriers: Results From A Combined Analysis Of 19 Studies
Authors: Antoniou A.C. , Sinilnikova O.M. , Simard J. , Léoné M. , Dumont M. , Neuhausen S.L. , Struewing J.P. , Stoppa-Lyonnet D. , Barjhoux L. , Hughes D.J. , et al. .
Source: American Journal Of Human Genetics, 2007 Dec; 81(6), p. 1186-200.
PMID: 17999359
Related Citations

Aurka F31i Polymorphism And Breast Cancer Risk In Brca1 And Brca2 Mutation Carriers: A Consortium Of Investigators Of Modifiers Of Brca1/2 Study
Authors: Couch F.J. , Sinilnikova O. , Vierkant R.A. , Pankratz V.S. , Fredericksen Z.S. , Stoppa-Lyonnet D. , Coupier I. , Hughes D. , Hardouin A. , Berthet P. , et al. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2007 Jul; 16(7), p. 1416-21.
PMID: 17627006
Related Citations

Prophylactic Oophorectomy In Women At Increased Cancer Risk
Authors: Domchek S.M. , Rebbeck T.R. .
Source: Current Opinion In Obstetrics & Gynecology, 2007 Feb; 19(1), p. 27-30.
PMID: 17218848
Related Citations

The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers.
Authors: Colilla S. , Kantoff P.W. , Neuhausen S.L. , Godwin A.K. , Daly M.B. , Narod S.A. , Garber J.E. , Lynch H.T. , Brown M. , Weber B.L. , et al. .
Source: Carcinogenesis, 2006 Mar; 27(3), p. 599-605.
PMID: 16244359
Related Citations

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.
Authors: Domchek S.M. , Friebel T.M. , Neuhausen S.L. , Wagner T. , Evans G. , Isaacs C. , Garber J.E. , Daly M.B. , Eeles R. , Matloff E. , et al. .
Source: The Lancet. Oncology, 2006 Mar; 7(3), p. 223-9.
PMID: 16510331
Related Citations

Bilateral Risk-reducing Oophorectomy In Brca1 And Brca2 Mutation Carriers
Authors: Domchek,S.M. , Stopfer,J.E. , Rebbeck,T.R. .
Source: Journal Of The National Comprehensive Cancer Network : Jnccn, 2006 Feb; 4(2), p. 177-82.
PMID: 16451773
Related Citations